Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Metabolic Disorders Drugs Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis

2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact

3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies
5.1 OxThera
5.1.1 OxThera Company Profile
5.1.2 OxThera Business Overview
5.1.3 OxThera Metabolic Disorders Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 OxThera Metabolic Disorders Drugs Products Introduction
5.2 Zealand Pharma
5.2.1 Zealand Pharma Company Profile
5.2.2 Zealand Pharma Business Overview
5.2.3 Zealand Pharma Metabolic Disorders Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Zealand Pharma Metabolic Disorders Drugs Products Introduction
5.3 Pronutria Biosciences
5.3.1 Pronutria Biosciences Company Profile
5.3.2 Pronutria Biosciences Business Overview
5.3.3 Pronutria Biosciences Metabolic Disorders Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Pronutria Biosciences Metabolic Disorders Drugs Products Introduction
5.4 CellCentric
5.4.1 CellCentric Company Profile
5.4.2 CellCentric Business Overview
5.4.3 CellCentric Metabolic Disorders Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 CellCentric Metabolic Disorders Drugs Products Introduction
5.5 Outpost Medicine
5.5.1 Outpost Medicine Company Profile
5.5.2 Outpost Medicine Business Overview
5.5.3 Outpost Medicine Metabolic Disorders Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Outpost Medicine Metabolic Disorders Drugs Products Introduction
5.6 Verva Pharmaceuticals
5.6.1 Verva Pharmaceuticals Company Profile
5.6.2 Verva Pharmaceuticals Business Overview
5.6.3 Verva Pharmaceuticals Metabolic Disorders Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Verva Pharmaceuticals Metabolic Disorders Drugs Products Introduction
5.7 Zafgen
5.7.1 Zafgen Company Profile
5.7.2 Zafgen Business Overview
5.7.3 Zafgen Metabolic Disorders Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Zafgen Metabolic Disorders Drugs Products Introduction
5.8 Mitobridge
5.8.1 Mitobridge Company Profile
5.8.2 Mitobridge Business Overview
5.8.3 Mitobridge Metabolic Disorders Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Mitobridge Metabolic Disorders Drugs Products Introduction
5.9 Nimbus Therapeutics
5.9.1 Nimbus Therapeutics Company Profile
5.9.2 Nimbus Therapeutics Business Overview
5.9.3 Nimbus Therapeutics Metabolic Disorders Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Nimbus Therapeutics Metabolic Disorders Drugs Products Introduction
5.10 Anchor Therapeutics
5.10.1 Anchor Therapeutics Company Profile
5.10.2 Anchor Therapeutics Business Overview
5.10.3 Anchor Therapeutics Metabolic Disorders Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Anchor Therapeutics Metabolic Disorders Drugs Products Introduction
5.11 MedGenome
5.11.1 MedGenome Company Profile
5.11.2 MedGenome Business Overview
5.11.3 MedGenome Metabolic Disorders Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 MedGenome Metabolic Disorders Drugs Products Introduction
5.12 Biophytis
5.12.1 Biophytis Company Profile
5.12.2 Biophytis Business Overview
5.12.3 Biophytis Metabolic Disorders Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 Biophytis Metabolic Disorders Drugs Products Introduction
5.13 Biophytis
5.13.1 Biophytis Company Profile
5.13.2 Biophytis Business Overview
5.13.3 Biophytis Metabolic Disorders Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 Biophytis Metabolic Disorders Drugs Products Introduction
5.14 Rhythm
5.14.1 Rhythm Company Profile
5.14.2 Rhythm Business Overview
5.14.3 Rhythm Metabolic Disorders Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 Rhythm Metabolic Disorders Drugs Products Introduction
5.15 PerkinElmer
5.15.1 PerkinElmer Company Profile
5.15.2 PerkinElmer Business Overview
5.15.3 PerkinElmer Metabolic Disorders Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 PerkinElmer Metabolic Disorders Drugs Products Introduction
5.16 Exelixis, Inc.
5.16.1 Exelixis, Inc. Company Profile
5.16.2 Exelixis, Inc. Business Overview
5.16.3 Exelixis, Inc. Metabolic Disorders Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.16.4 Exelixis, Inc. Metabolic Disorders Drugs Products Introduction
5.17 Eternygen
5.17.1 Eternygen Company Profile
5.17.2 Eternygen Business Overview
5.17.3 Eternygen Metabolic Disorders Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.17.4 Eternygen Metabolic Disorders Drugs Products Introduction

6 Market Analysis and Forecast, By Product Types
6.1 Global Metabolic Disorders Drugs Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Metabolic Disorders Drugs Sales and Market Share by Types (2015-2020)
6.1.2 Global Metabolic Disorders Drugs Revenue and Market Share by Types (2015-2020)
6.1.3 Global Metabolic Disorders Drugs Price by Types (2015-2020)
6.2 Global Metabolic Disorders Drugs Market Forecast by Types (2020-2025)
6.2.1 Global Metabolic Disorders Drugs Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Metabolic Disorders Drugs Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Metabolic Disorders Drugs Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Metabolic Disorders Drugs Sales, Price and Growth Rate of Tablet
6.3.2 Global Metabolic Disorders Drugs Sales, Price and Growth Rate of Injection
6.4 Global Metabolic Disorders Drugs Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Tablet Market Revenue and Sales Forecast (2020-2025)
6.4.2 Injection Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications
7.1 Global Metabolic Disorders Drugs Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Metabolic Disorders Drugs Sales and Market Share by Applications (2015-2020)
7.1.2 Global Metabolic Disorders Drugs Revenue and Market Share by Applications (2015-2020)
7.2 Global Metabolic Disorders Drugs Market Forecast by Applications (2020-2025)
7.2.1 Global Metabolic Disorders Drugs Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Metabolic Disorders Drugs Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Metabolic Disorders Drugs Revenue, Sales and Growth Rate of Diabetes (2015-2020)
7.3.2 Global Metabolic Disorders Drugs Revenue, Sales and Growth Rate of Disorders of the Thyroid and Pituitary Gland (2015-2020)
7.3.3 Global Metabolic Disorders Drugs Revenue, Sales and Growth Rate of Other (2015-2020)
7.4 Global Metabolic Disorders Drugs Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Diabetes Market Revenue and Sales Forecast (2020-2025)
7.4.2 Disorders of the Thyroid and Pituitary Gland Market Revenue and Sales Forecast (2020-2025)
7.4.3 Other Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions
8.1 Global Metabolic Disorders Drugs Sales by Regions (2015-2020)
8.2 Global Metabolic Disorders Drugs Market Revenue by Regions (2015-2020)
8.3 Global Metabolic Disorders Drugs Market Forecast by Regions (2020-2025)

9 North America Metabolic Disorders Drugs Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Metabolic Disorders Drugs Market Sales and Growth Rate (2015-2020)
9.3 North America Metabolic Disorders Drugs Market Revenue and Growth Rate (2015-2020)
9.4 North America Metabolic Disorders Drugs Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Metabolic Disorders Drugs Market Analysis by Country
9.6.1 U.S. Metabolic Disorders Drugs Sales and Growth Rate
9.6.2 Canada Metabolic Disorders Drugs Sales and Growth Rate
9.6.3 Mexico Metabolic Disorders Drugs Sales and Growth Rate

10 Europe Metabolic Disorders Drugs Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Metabolic Disorders Drugs Market Sales and Growth Rate (2015-2020)
10.3 Europe Metabolic Disorders Drugs Market Revenue and Growth Rate (2015-2020)
10.4 Europe Metabolic Disorders Drugs Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Metabolic Disorders Drugs Market Analysis by Country
10.6.1 Germany Metabolic Disorders Drugs Sales and Growth Rate
10.6.2 United Kingdom Metabolic Disorders Drugs Sales and Growth Rate
10.6.3 France Metabolic Disorders Drugs Sales and Growth Rate
10.6.4 Italy Metabolic Disorders Drugs Sales and Growth Rate
10.6.5 Spain Metabolic Disorders Drugs Sales and Growth Rate
10.6.6 Russia Metabolic Disorders Drugs Sales and Growth Rate

11 Asia-Pacific Metabolic Disorders Drugs Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Metabolic Disorders Drugs Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Metabolic Disorders Drugs Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Metabolic Disorders Drugs Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Metabolic Disorders Drugs Market Analysis by Country
11.6.1 China Metabolic Disorders Drugs Sales and Growth Rate
11.6.2 Japan Metabolic Disorders Drugs Sales and Growth Rate
11.6.3 South Korea Metabolic Disorders Drugs Sales and Growth Rate
11.6.4 Australia Metabolic Disorders Drugs Sales and Growth Rate
11.6.5 India Metabolic Disorders Drugs Sales and Growth Rate

12 South America Metabolic Disorders Drugs Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Metabolic Disorders Drugs Market Sales and Growth Rate (2015-2020)
12.3 South America Metabolic Disorders Drugs Market Revenue and Growth Rate (2015-2020)
12.4 South America Metabolic Disorders Drugs Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Metabolic Disorders Drugs Market Analysis by Country
12.6.1 Brazil Metabolic Disorders Drugs Sales and Growth Rate
12.6.2 Argentina Metabolic Disorders Drugs Sales and Growth Rate
12.6.3 Columbia Metabolic Disorders Drugs Sales and Growth Rate

13 Middle East and Africa Metabolic Disorders Drugs Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Metabolic Disorders Drugs Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Metabolic Disorders Drugs Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Metabolic Disorders Drugs Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Metabolic Disorders Drugs Market Analysis by Country
13.6.1 UAE Metabolic Disorders Drugs Sales and Growth Rate
13.6.2 Egypt Metabolic Disorders Drugs Sales and Growth Rate
13.6.3 South Africa Metabolic Disorders Drugs Sales and Growth Rate

14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors

15 Appendix
15.1 Methodology
15.2 Research Data Source